Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yohei Ohno

Showing results (81-90 of 192) with videos related to

Pageof 20
Sort By:
JACC. Advances|June 28, 2024
Pathological Analysis of Medial and Intimal Calcification in Lower Extremity Artery Disease: Impact of HemodialysisTsukasa Kato, Sho Torii, Norihito Nakamura, et al.
Contemporary Clinical Trials|October 18, 2023
Rationale and design of Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation (NAPT) TrialTaku Inohara, Toshiaki Otsuka, Yusuke Watanabe, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 19, 2024
Comparative Data of Procedural and Midterm Outcomes in Patients Who Underwent Percutaneous Left Atrial Appendage Closure Between the WATCHMAN FLX and WATCHMAN 2.5 Devices　- Insight From the OCEAN-LAAC RegistryMasaki Nakashima, Masanori Yamamoto, Mitsuru Sago, et al.
American Heart Journal|August 9, 2024
Pathological evaluation of predictors for delayed endothelial coverage after currently available drug-eluting stent implantation in coronary arteries: Impact of lesions with acute and chronic coronary syndromesKazuki Aihara, Sho Torii, Norihito Nakamura, et al.
JACC. Cardiovascular Interventions|December 16, 2014
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registryGuilherme F Attizzani, Yohei Ohno, Davide Capodanno, et al.
Circulation Research|February 20, 2010
Zac1 is an essential transcription factor for cardiac morphogenesisShinsuke Yuasa, Takeshi Onizuka, Kenichiro Shimoji, et al.
ESC Heart Failure|August 21, 2024
Transcatheter aortic valve implantation for combined aortic and mitral stenoses: Insights from the OCEAN-TAVI RegistryNahoko Kato, Minoru Tabata, Masahiko Noguchi, et al.
JAMA Cardiology|December 17, 2025
Low-Density Lipoprotein Cholesterol Levels and Neoatherosclerosis After STEMI: A Secondary Analysis of the CONNECT Randomized Clinical TrialJonas Dominik Häner, Ryota Kakizaki, Masanori Taniwaki, et al.
European Heart Journal|September 1, 2024
Long-term effect of biodegradable vs durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trialMasanori Taniwaki, Jonas Dominik Häner, Ryota Kakizaki, et al.
JACC. Asia|April 25, 2024
Pre-Existing Left Bundle Branch Block and Clinical Outcomes After Transcatheter Aortic Valve ReplacementTetsuya Saito, Taku Inohara, Hikaru Tsuruta, et al.
Pageof 20

Showing results (81-90 of 192) with videos related to

Sort By:
Pageof 20
JACC. Advances|June 28, 2024
Pathological Analysis of Medial and Intimal Calcification in Lower Extremity Artery Disease: Impact of HemodialysisTsukasa Kato, Sho Torii, Norihito Nakamura, et al.
Contemporary Clinical Trials|October 18, 2023
Rationale and design of Non-antithrombotic Therapy After Transcatheter Aortic Valve Implantation (NAPT) TrialTaku Inohara, Toshiaki Otsuka, Yusuke Watanabe, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|May 19, 2024
Comparative Data of Procedural and Midterm Outcomes in Patients Who Underwent Percutaneous Left Atrial Appendage Closure Between the WATCHMAN FLX and WATCHMAN 2.5 Devices　- Insight From the OCEAN-LAAC RegistryMasaki Nakashima, Masanori Yamamoto, Mitsuru Sago, et al.
American Heart Journal|August 9, 2024
Pathological evaluation of predictors for delayed endothelial coverage after currently available drug-eluting stent implantation in coronary arteries: Impact of lesions with acute and chronic coronary syndromesKazuki Aihara, Sho Torii, Norihito Nakamura, et al.
JACC. Cardiovascular Interventions|December 16, 2014
Extended use of percutaneous edge-to-edge mitral valve repair beyond EVEREST (Endovascular Valve Edge-to-Edge Repair) criteria: 30-day and 12-month clinical and echocardiographic outcomes from the GRASP (Getting Reduction of Mitral Insufficiency by Percutaneous Clip Implantation) registryGuilherme F Attizzani, Yohei Ohno, Davide Capodanno, et al.
Circulation Research|February 20, 2010
Zac1 is an essential transcription factor for cardiac morphogenesisShinsuke Yuasa, Takeshi Onizuka, Kenichiro Shimoji, et al.
ESC Heart Failure|August 21, 2024
Transcatheter aortic valve implantation for combined aortic and mitral stenoses: Insights from the OCEAN-TAVI RegistryNahoko Kato, Minoru Tabata, Masahiko Noguchi, et al.
JAMA Cardiology|December 17, 2025
Low-Density Lipoprotein Cholesterol Levels and Neoatherosclerosis After STEMI: A Secondary Analysis of the CONNECT Randomized Clinical TrialJonas Dominik Häner, Ryota Kakizaki, Masanori Taniwaki, et al.
European Heart Journal|September 1, 2024
Long-term effect of biodegradable vs durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trialMasanori Taniwaki, Jonas Dominik Häner, Ryota Kakizaki, et al.
JACC. Asia|April 25, 2024
Pre-Existing Left Bundle Branch Block and Clinical Outcomes After Transcatheter Aortic Valve ReplacementTetsuya Saito, Taku Inohara, Hikaru Tsuruta, et al.
Pageof 20